在患有遗传性心肌病的儿科患者中长期的Impella 5.5支持
David Rekhtman1, Michaela Asher1, Cindy Song1
1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
概括
这个案例研究详细介绍了一个14岁的孩子.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 儿科 儿科 儿科
背景情况:
- 临时机械循环支持 (tMCS) 越来越多地用于心脏移植候选人.
- 长时间的支持持续时间带来了独特的挑战,特别是在儿科患者中.
研究的目的:
- 报告一个患有特定基因突变的儿科患者长期tMCS的独特病例.
- 突出了并发症的管理和在延长的TMCS期间需要多学科护理的必要性.
主要方法:
- 一名患有TNNT2和KCNQ1突变的14岁患者接受了Impella 5.5支持.
- 记录了临床过程,遗传因素和支持管理.
主要成果:
- 患者获得了76天的Impella 5.5支持,这是使用该设备的儿科患者创纪录的持续时间.
- 这一案例突显了尽管遗传病因复杂,但成功管理.
结论:
- 这一案例证明了在精选的儿科患者中延长临时机械循环支持的可行性.
- 多学科的支持对于管理长期的tMCS和相关的遗传疾病至关重要.
相关概念视频
Cardiomyopathy V: Interprofessional Care
40
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
40
Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Cardiomyopathy III: Hypertrophic Cardiomyopathy
64
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
64
Cardiomyopathy IV: Restrictive Cardiomyopathy
42
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
42
Cardiomyopathy VI: Nursing Management
47
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
47
Heart Failure Drugs: Inotropic Agents
743
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
743


